RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/SHA-384/A22D29BAFE2826779BB324BF214CC0B2C36FC03BD423339A573AE9915911DC6657D7716B33CD7C99FC61DC4EF862EF61http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/A22D29BAFE2826779BB324BF214CC0B2C36FC03BD423339A573AE9915911DC6657D7716B33CD7C99FC61DC4EF862EF61http://www.w3.org/2000/01/rdf-schema#comment"CRY-1 was expressed in 94% of the CLL patients at diagnosis. The median CRY-1 relative gene expression level (0.006) stratified patients into high and low expression groups. Forty of 100 (40%) CLL patients showed high CRY-1 54/100 (54%) showed low CRY-1 and 6/100 (6%) had undetectable CRY-1 gene expression."xsd:string
http://purl.uniprot.org/uniprot/#_C89482D99FBBDF10C4490262E301BC1A5665CDCB1A56EEA3657E6755A9A64D46AD1BFB5A309C4328F9C6786429F820F1http://www.w3.org/1999/02/22-rdf-syntax-ns#subjecthttp://purl.uniprot.org/SHA-384/A22D29BAFE2826779BB324BF214CC0B2C36FC03BD423339A573AE9915911DC6657D7716B33CD7C99FC61DC4EF862EF61
http://purl.uniprot.org/uniprot/Q16526http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/A22D29BAFE2826779BB324BF214CC0B2C36FC03BD423339A573AE9915911DC6657D7716B33CD7C99FC61DC4EF862EF61
http://purl.uniprot.org/uniprot/#_Q16526-mappedCitation-28884705http://purl.uniprot.org/core/mappedAnnotationhttp://purl.uniprot.org/SHA-384/A22D29BAFE2826779BB324BF214CC0B2C36FC03BD423339A573AE9915911DC6657D7716B33CD7C99FC61DC4EF862EF61